Stay updated on Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision history now shows an added entry for v3.3.2 and a removed entry for v3.2.0. This is an administrative update to the history log; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T16:59:39.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    - Removed the funding-lapse notice that warned about potential delays and directed users to opm.gov.
    Difference
    0.6%
    Check dated 2025-11-17T15:00:12.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The latest version updates the record with changes to the study status and recruitment status, reflecting the trial's current state and related details.
    Difference
    0.1%
    Check dated 2025-11-03T01:30:08.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a government funding and operating status notice and operating details for NIH Clinical Center. - Updated software version from v3.1.0 to v3.2.0.
    Difference
    11%
    Check dated 2025-10-05T12:07:33.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T09:27:28.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Updated study results page status to posted with expanded sections; removed the old “Results Submitted” label.
    Difference
    5%
    Check dated 2025-09-21T06:25:26.000Z thumbnail image

Stay in the know with updates to Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.